Centiva Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,515
Closed -$1.45M 1366
2025
Q2
$1.45M Buy
18,515
+8,352
+82% +$623K 0.1% 458
2025
Q1
$737K Buy
10,163
+1,053
+12% +$75.4K 0.04% 614
2024
Q4
$674K Buy
9,110
+4,641
+104% +$325K 0.03% 667
2024
Q3
$295K Buy
+4,469
New +$325K 0.01% 1590
2024
Q2
Sell
-19,607
Closed -$1.87M 2193
2024
Q1
$1.87M Buy
19,607
+12,672
+183% +$1.06M 0.11% 371
2023
Q4
$529K Sell
6,935
-16,118
-70% -$1.12M 0.03% 935
2023
Q3
$1.6M Buy
23,053
+3,961
+21% +$318K 0.08% 460
2023
Q2
$1.8M Buy
+19,092
New +$1.66M 0.09% 414
2022
Q4
Sell
-3,171
Closed -$262K 1454
2022
Q3
$262K Buy
+3,171
New +$305K 0.02% 1094
2021
Q3
Sell
-3,988
Closed -$413K 1380
2021
Q2
$413K Buy
+3,988
New +$376K 0.03% 900
2020
Q4
Sell
-10,559
Closed -$843K 971
2020
Q3
$843K Sell
10,559
-4,040
-28% -$315K 0.13% 230
2020
Q2
$1.01M Buy
+14,599
New +$1.04M 0.23% 174
2020
Q1
Sell
-9,462
Closed -$736K 713
2019
Q4
$736K Buy
+9,462
New +$739K 0.13% 341
2019
Q3
Sell
-1,662
Closed -$117K 650
2019
Q2
$102K Buy
+1,662
New +$100K 0.02% 367

Other funds holding EW